StockNews.AI
TCMD
StockNews.AI
120 days

Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025

1. TCMD will release Q1 2025 financial results on May 5. 2. Management to host a conference call and Q&A session on the same day. 3. TCMD specializes in therapies for chronic conditions like lymphedema and lipedema. 4. Company aims to improve patient care and reduce healthcare costs. 5. A replay of the call will be available for two weeks afterward.

Earnings
+2.6%Current Return
VS
+2.57%S&P 500
$13.4504/21 04:14 PM EDTEvent Start
$13.804/22 10:42 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

The upcoming financial results and conference call often generate investor interest. If recent performance is positive, it may lead to a price increase.

How important is it?

Earnings reports are crucial for stock evaluation, impacting investor sentiment and decisions.

Why Short Term?

The release of earnings reports traditionally influences immediate market reactions and stock performance.

Related Companies

ABMDMDTBSX
April 21, 2025 16:05 ET  | Source: Tactile Systems Technology, Inc. MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 5, 2025, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13752588. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com. For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13752588. The webcast will be archived at investors.tactilemedical.com. About Tactile Systems Technology, Inc. (DBA Tactile Medical) Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year. Investor Inquiries:Sam BentzingerGilmartin Groupinvestorrelations@tactilemedical.com

Related News